Table 3.
Variable | Univariate analysis |
Multivariate analysis |
||||
---|---|---|---|---|---|---|
OR | 95% CI | P-value | OR | 95% CI | P-value | |
Age | 0.984 | 0.946–1.023 | 0.418 | |||
Male sex | 0.950 | 0.401–2.248 | 0.907 | |||
RB location | 1.130 | 0.349–3.660 | 0.838 | |||
cT4 | 0.000 | 0.000–∞ | 0.989 | |||
cN+ | 0.221 | 0.099–0.554 | 0.001 | 0.244 | 0.091–0.651 | 0.005 |
PD/MUC | 0.625 | 0.072–5.407 | 0.669 | |||
Delay after RT | 0.975 | 0.747–1.274 | 0.854 | |||
CEA> 3.3 ng/mL | 0.250 | 0.102–0.615 | 0.003 | 0.284 | 0.109–0.783 | 0.010 |
pre-nCRT NLR > 2.77 | 0.296 | 0.096–0.913 | 0.034 | |||
post-nCRT NLR > 3.23 | 0.372 | 0.160–0.864 | 0.021 | 0.365 | 0.145–0.918 | 0.032 |
OR, odds ratio; CI, confidence interval; RB, below peritoneal reflection; RT, radiotherapy; CEA, carcinoembryonic antigen; nCRT, neoadjuvant chemoradiation therapy; NLR, neutrophil to lymphocyte ratio.